Laetitia Serrano

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

Houriiyah Tegally, James Emmanuel San, Matthew Cotten et al. · Science · 2022 · 179 citations · Full text

Life Sciences, Health Sciences, Infectious Diseases +14

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack et al. · The Lancet HIV · 2020 · 164 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Putative involvement of crustacean hyperglycemic hormone isoforms in the neuroendocrine mediation of osmoregulation in the crayfish<i>Astacus leptodactylus</i>

Laetitia Serrano, Gaëlle Blanvillain, Daniel Soyez et al. · Journal of Experimental Biology · 2003 · 118 citations

Life Sciences, Biochemistry, Endocrinology +14

High rates of virological failure and drug resistance in perinatally HIV‐1‐infected children and adolescents receiving lifelong antiretroviral therapy in routine clinics in Togo

Mounérou Salou, Anoumou Dagnra, Christelle Butel et al. · Journal of the International AIDS Society · 2016 · 89 citations · Full text

Public Health, Child Health, Pediatrics +16

Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial

Laura Ciaffi, Sinata Koulla‐Shiro, Adrien Sawadogo et al. · The Lancet HIV · 2017 · 72 citations

Public Health, Community Health, Pharmacotherapy +17